TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma: As briefly mentioned above, CD30+ LPDs account for the second most common CTCL subtype after MF, which histologically presents large CD30+ tumor cells and is characterized by an indolent course and a favorable prognosis [5].